This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Aceragen Bilan de santé
Santé financière contrôle des critères 2/6
Aceragen has a total shareholder equity of $57.3M and total debt of $733.0K, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are $78.5M and $21.1M respectively.
Informations clés
1.3%
Ratio d'endettement
US$733.00k
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$2.12m |
| Fonds propres | US$57.35m |
| Total du passif | US$21.14m |
| Total des actifs | US$78.49m |
Mises à jour récentes de la santé financière
We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24
We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07Recent updates
Idera Pharmaceuticals completes acquisition of Aceragen
Sep 28We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Aug 24We Think Idera Pharmaceuticals (NASDAQ:IDRA) Needs To Drive Business Growth Carefully
May 11Is Idera Pharmaceuticals (NASDAQ:IDRA) In A Good Position To Deliver On Growth Plans?
Mar 07When Will Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Become Profitable?
Jan 31Idera outlines capital requirement to move tilsotolimod toward commercialization in advanced melanoma
Jan 13Could The Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Ownership Structure Tell Us Something Useful?
Dec 27Don't Ignore The Fact That This Insider Just Sold Some Shares In Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Dec 27Idera Pharmaceuticals receives $5M in additional proceeds from private placement
Dec 15We're Keeping An Eye On Idera Pharmaceuticals' (NASDAQ:IDRA) Cash Burn Rate
Nov 25Idera Pharma names new operations chief
Nov 17Idera Pharmaceuticals EPS misses by $0.37
Oct 29Analyse de la situation financière
Passif à court terme: ACGN's short term assets ($5.6M) do not cover its short term liabilities ($17.9M).
Passif à long terme: ACGN's short term assets ($5.6M) exceed its long term liabilities ($3.3M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: ACGN has more cash than its total debt.
Réduire la dette: ACGN's debt to equity ratio has increased from 0.1% to 1.3% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: ACGN has less than a year of cash runway based on its current free cash flow.
Prévisions de trésorerie: ACGN has less than a year of cash runway if free cash flow continues to grow at historical rates of 13.3% each year.